
Smart Medical Devices Market Report By Product Type (Diagnostic and Monitoring Devices, Modality - Wearable, Non-Wearable, Therapeutic Devices, Injury Prevention and Rehabilitation Devices), By Application (Blood glucose & pressure monitoring, Cardiovascular monitoring, Fetal Monitors, Pulse Oximeters, Breathe Analyzers, Others), By End-user, By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033
-
46313
-
May 2024
-
325
-
-
This report was compiled by Trishita Deb Trishita Deb is an experienced market research and consulting professional with over 7 years of expertise across healthcare, consumer goods, and materials, contributing to over 400 healthcare-related reports. Correspondence Team Lead- Healthcare Linkedin | Detailed Market research Methodology Our methodology involves a mix of primary research, including interviews with leading mental health experts, and secondary research from reputable medical journals and databases. View Detailed Methodology Page
-
Quick Navigation
Report Overview
The Global Smart Medical Devices Market size is expected to be worth around USD 75.5 billion by 2033, from USD 37.3 billion in 2023, growing at a CAGR of 7.5% during the forecast period from 2024 to 2033.
The Smart Medical Devices Market encompasses advanced medical devices with integrated technology. These devices monitor, diagnose, and treat patients more effectively. They include wearable devices, smart implants, and connected diagnostic tools. Growth is fueled by the increasing demand for remote patient monitoring, chronic disease management, and personalized healthcare.
Key players are Medtronic, Philips Healthcare, and Abbott. The market benefits from technological advancements, aging populations, and rising healthcare costs. Smart medical devices enhance patient care, improve healthcare efficiency, and support data-driven decision-making.
The Smart Medical Devices Market is poised for substantial growth, driven by advancements in technology and increasing healthcare needs. Medical technology companies are significantly investing in research and development, with an average of 5.1% of their annual revenue dedicated to R&D. In particular, MedTech companies in the US and UK have increased their R&D investments by 11.5%. This substantial investment is fostering innovation and the development of sophisticated medical devices.
Artificial Intelligence (AI) is a key driver in this market, enabling earlier and more accurate detection of diseases such as breast cancer and lung cancer. AI algorithms can review mammograms 30 times faster than conventional methods, achieving nearly 100% accuracy. This capability not only enhances diagnostic precision but also reduces the need for unnecessary biopsies, thereby improving patient outcomes and reducing healthcare costs.
The integration of smart technology in medical devices offers numerous benefits, including remote monitoring, real-time data analysis, and personalized treatment. These features are particularly valuable in managing chronic diseases, where continuous monitoring and timely interventions are crucial.
Furthermore, the aging global population is driving demand for smart medical devices that support independent living and manage age-related conditions. As healthcare systems worldwide face the challenge of providing quality care to an increasing number of elderly patients, smart medical devices are becoming essential tools in delivering efficient and effective healthcare.
In summary, the Smart Medical Devices Market is experiencing dynamic growth, supported by robust R&D investments and technological innovations like AI. These advancements are transforming healthcare delivery, offering significant benefits for both patients and providers. The market's future looks promising as it continues to evolve and meet the growing demands of the healthcare sector.
Key Takeaways
- Market Value: The Global Smart Medical Devices Market is expected to grow from USD 37.3 billion in 2023 to approximately USD 75.5 billion by 2033, at a CAGR of 7.5%.
- Product Type Analysis: Diagnostic and Monitoring Devices dominate with 32.11% due to their extensive application in health monitoring and diagnostics.
- Application Analysis: Cardiovascular monitoring dominates with 26.72% due to its critical role in managing heart diseases.
- End-User Analysis: Hospitals dominate with 25.90% due to their extensive use of smart medical devices for patient care and diagnostics.
- Distribution Channel Analysis: Pharmacies dominate with 56.24% due to their accessibility and professional support for consumers.
- Dominant Region: North America dominates with 43.87% market share due to advanced healthcare infrastructure and high adoption of smart medical devices.
- High Growth Region: Europe holds a significant share of the market with a projected growth rate of 8.5% CAGR, driven by significant healthcare investments and an aging population.
- Analyst Viewpoint: The overall market is experiencing steady growth with moderate competition, driven by technological advancements and increasing prevalence of chronic diseases. Future trends include greater adoption of wearable and home-based devices, and integration of AI for enhanced diagnostics and monitoring.
Driving Factors
Rising Prevalence of Chronic Diseases Drives Market Growth
The smart medical devices market is experiencing robust growth due to the increasing prevalence of chronic diseases globally. Chronic diseases such as diabetes, cardiovascular conditions, and respiratory disorders are becoming more common, necessitating continuous health monitoring. Smart medical devices equipped with IoT capabilities and advanced sensors enable continuous monitoring and real-time data transmission, thereby improving disease management and patient outcomes.
For example, continuous glucose monitoring (CGM) systems like Abbott's FreeStyle Libre have revolutionized diabetes management. These devices provide patients with real-time glucose readings and trends, reducing the need for traditional fingerstick tests. This growth is driven by the increasing number of diabetic patients and the demand for effective disease management solutions.
The interaction of these devices with other healthcare technologies enhances their impact. For instance, data from CGM systems can be integrated into telemedicine platforms, allowing healthcare providers to offer personalized care remotely. This integration not only improves patient outcomes but also reduces healthcare costs, contributing to the overall growth of the smart medical devices market.
Technological Advancements in Wearable Devices Drive Market Growth
The evolution of wearable technology has significantly contributed to the growth of smart medical devices. Innovations in miniaturization, battery life, and connectivity have enabled the development of wearable health monitors that track vital signs, physical activity, and detect abnormalities. Wearable devices such as Apple Watch Series 6, which includes an FDA-cleared ECG app and blood oxygen monitoring, exemplify the integration of health monitoring into everyday devices.
Wearable health devices have seen widespread adoption due to their convenience and ability to provide continuous health data. This growth is driven by the increasing consumer demand for health and fitness tracking, as well as the need for continuous health monitoring for chronic disease management.
These advancements interact with other healthcare technologies to enhance their effectiveness. For instance, wearable devices can transmit health data to electronic health records (EHR) systems, enabling healthcare providers to monitor patients remotely and make informed decisions. This connectivity not only improves patient care but also supports the growth of telemedicine, further driving the expansion of the smart medical devices market.
Remote Patient Monitoring and Telemedicine Adoption Drive Market Growth
The shift towards remote patient monitoring and telemedicine services has accelerated the demand for smart medical devices. These devices allow healthcare providers to remotely monitor patients' health status, reducing hospital admissions and healthcare costs. For example, Philips' IntelliVue Guardian solution uses advanced algorithms and predictive analytics to monitor patients' vital signs in hospital and home settings, enabling early intervention and improved patient care.
Remote patient monitoring (RPM) has become essential, especially during the COVID-19 pandemic, which increased the need for remote healthcare solutions. This growth is driven by the increasing adoption of telemedicine and the need for continuous health monitoring, particularly for chronic disease management.
The synergy between RPM and telemedicine enhances their impact on the market. For instance, data collected from RPM devices can be shared with healthcare providers through telemedicine platforms, enabling real-time patient monitoring and timely interventions. This integration not only improves patient outcomes but also reduces the burden on healthcare facilities, contributing to the overall growth of the smart medical devices market.
Restraining Factors
High Costs and Reimbursement Challenges Restrain Market Growth
High costs and reimbursement issues significantly hinder the adoption of smart medical devices. These devices require substantial investments in research, development, and regulatory compliance, leading to higher retail prices. For instance, continuous glucose monitoring systems, despite their benefits, can be expensive. Limited insurance coverage further exacerbates this issue, making these devices unaffordable for many patients.
According to a report, the average cost of a CGM system ranges from $1,000 to $5,000 per year. This financial barrier limits the widespread adoption of smart medical devices, affecting market growth. Additionally, inconsistent reimbursement policies across different healthcare systems contribute to this challenge, as not all insurance plans cover the costs of advanced medical devices.
Data Security and Privacy Concerns Restrain Market Growth
Data security and privacy concerns pose significant challenges to the growth of the smart medical devices market. These devices collect and transmit sensitive health information over networks, making them vulnerable to cyber-attacks and data breaches. A notable example is the 2019 recall of certain insulin pumps due to cybersecurity vulnerabilities.
Such incidents underscore the need for robust cybersecurity measures to protect patient data and ensure device safety. According to a report, healthcare data breaches exposed over 40 million patient records in 2019 alone. The potential risks associated with data breaches can deter both healthcare providers and patients from adopting smart medical devices, thus restraining market growth.
Product Type Analysis
Diagnostic and Monitoring Devices dominate with 32.11% due to their extensive application in health monitoring and diagnostics.
The smart medical devices market is segmented by product type into diagnostic and monitoring devices, therapeutic devices, and injury prevention and rehabilitation devices. Diagnostic and monitoring devices dominate this segment, accounting for 32.11% of the market. These devices include modalities like wearable and non-wearable technologies, which play crucial roles in health management.
Wearable devices are the most prominent sub-segment within diagnostic and monitoring devices. They have gained significant traction due to their convenience, real-time data tracking, and integration with mobile health applications. Examples include smartwatches with ECG functions, fitness trackers, and continuous glucose monitors. These devices cater to the growing consumer demand for proactive health monitoring and fitness management.
Non-wearable diagnostic devices also contribute significantly to market growth. These include traditional medical equipment enhanced with smart technologies, such as digital blood pressure monitors, advanced imaging systems, and non-invasive diagnostic tools. Although non-wearable devices are less portable than their wearable counterparts, they are crucial for precise diagnostics in clinical settings. The advancements in sensor technology and data analytics have improved the accuracy and functionality of these devices, making them indispensable in modern healthcare.
Therapeutic devices are another critical segment, although they currently have a smaller market share compared to diagnostic and monitoring devices. These include devices used for pain management, respiratory therapy, and other treatments. The increasing prevalence of chronic diseases and the demand for home-based healthcare solutions drive the growth of this segment. Devices such as smart inhalers, connected nebulizers, and wearable pain relief patches are becoming more popular due to their ability to deliver personalized therapy and monitor patient compliance.
Injury prevention and rehabilitation devices also play a significant role in the smart medical devices market. These devices are designed to aid recovery and prevent further injury, particularly in sports medicine and orthopedics. Smart braces, connected physiotherapy equipment, and wearable sensors that monitor rehabilitation progress are examples of this sub-segment. The growing awareness of the importance of injury prevention and the increasing participation in sports and physical activities contribute to the expansion of this market segment.
Application Analysis
Cardiovascular monitoring dominates with 26.72% due to its critical role in managing heart diseases.
The application segment of the smart medical devices market encompasses various uses such as blood glucose and pressure monitoring, cardiovascular monitoring, fetal monitors, pulse oximeters, breath analyzers, body motion sensors, insulin monitoring, hearing aids, and others. Among these, cardiovascular monitoring is the dominant sub-segment, holding 26.72% of the market share.
Cardiovascular monitoring devices are essential for managing heart diseases, which are among the leading causes of death worldwide. These devices, including smartwatches with ECG capabilities and portable heart monitors, provide continuous heart health data, enabling early detection and timely intervention. The increasing incidence of cardiovascular diseases, coupled with the aging population, drives the demand for these devices. The global cardiovascular monitoring market is expected to grow significantly, driven by advancements in wearable technology and the integration of AI for predictive analytics.
Blood glucose and pressure monitoring devices are also crucial applications within this market. Continuous glucose monitors and smart blood pressure monitors offer real-time tracking and management of diabetes and hypertension, respectively. The prevalence of these chronic conditions is rising, necessitating effective monitoring solutions to manage patient health proactively.
Other notable applications include fetal monitors, pulse oximeters, and breath analyzers. Fetal monitors are essential for monitoring the health of the fetus during pregnancy, providing critical data for prenatal care. Pulse oximeters, especially during the COVID-19 pandemic, have become vital for monitoring blood oxygen levels, with increased adoption in both clinical and home settings. Breath analyzers are used for detecting various conditions, including respiratory diseases and alcohol levels, contributing to public health and safety.
Body motion sensors and insulin monitoring devices also play significant roles. Body motion sensors are used in fitness trackers and rehabilitation devices to monitor physical activity and recovery progress. Insulin monitoring devices are critical for diabetes management, providing real-time data to adjust insulin doses accurately.
End-User Analysis
Hospitals dominate with 25.90% due to their extensive use of smart medical devices for patient care and diagnostics.
The end-user segment of the smart medical devices market includes hospitals, clinics, home care settings, and others. Hospitals are the dominant end-user, holding 25.90% of the market share. Hospitals rely heavily on smart medical devices for accurate diagnostics, patient monitoring, and effective treatment.
Hospitals use a wide range of smart medical devices, including advanced imaging systems, diagnostic tools, and monitoring devices. These devices are integral to providing high-quality patient care, enabling early diagnosis, and continuous monitoring of critical patients. The high adoption rate of these devices in hospitals is driven by the need for precision, efficiency, and improved patient outcomes. The increasing number of hospital admissions and the growing prevalence of chronic diseases further fuel the demand for smart medical devices in this setting.
Clinics also play a significant role in the market, using smart medical devices for outpatient care and routine check-ups. These devices help clinics provide efficient and accurate services, enhancing patient satisfaction and care quality. The use of portable and easy-to-use devices in clinics supports the growing trend of point-of-care diagnostics.
Home care settings are becoming increasingly important as the demand for home-based healthcare solutions rises. Smart medical devices for home use, such as wearable health monitors, connected blood pressure cuffs, and glucose monitors, enable patients to manage their health conditions effectively from the comfort of their homes. The shift towards home healthcare is driven by the aging population, the need for chronic disease management, and the desire to reduce hospital visits and healthcare costs.
Other end-users, including ambulatory surgical centers and research institutes, also contribute to the market. These facilities use smart medical devices for various applications, including surgical procedures, clinical trials, and medical research. The adoption of these devices in diverse settings highlights their versatility and importance in modern healthcare.
Distribution Channel Analysis
Pharmacies dominate with 56.24% due to their accessibility and professional support for consumers.
The distribution channel segment of the smart medical devices market includes pharmacies, online channels, and others (hypermarkets). Pharmacies dominate this segment, holding 56.24% of the market share. Pharmacies are the primary distribution channel for smart medical devices, providing easy access to consumers.
Pharmacies offer a wide range of smart medical devices, including blood pressure monitors, glucose meters, and wearable health trackers. The convenience and accessibility of pharmacies make them a preferred choice for purchasing these devices. Additionally, pharmacies often provide professional advice and support, helping consumers make informed decisions about their health.
Online channels are rapidly gaining popularity as a distribution channel for smart medical devices. The convenience of online shopping, coupled with the availability of a wide range of products and competitive pricing, drives the growth of this segment. The increasing use of e-commerce platforms and the rise of digital health initiatives contribute to the expansion of online channels. Consumers can easily compare products, read reviews, and make purchases from the comfort of their homes.
Other distribution channels, such as hypermarkets, also play a role in the market. Hypermarkets offer smart medical devices alongside other consumer goods, providing a one-stop shopping experience. The presence of smart medical devices in hypermarkets increases their visibility and accessibility to a broader audience.
Key Market Segments
By Product Type
- Diagnostic and Monitoring Devices
- Modality
- Wearable
- Non-Wearable
- Modality
- Therapeutic Devices
- Injury Prevention and Rehabilitation Devices
By Application
- Blood glucose & pressure monitoring
- Cardiovascular monitoring
- Fetal Monitors
- Pulse Oximeters
- Breathe Analyzers
- Body Motion
- Insulin Monitoring
- Hearing aids
- Others
By End-user
- Hospitals
- Clinics
- Home Care Settings
- Others
Distribution Channel
- Pharmacies
- Online channel
- Others (hypermarkets)
Growth Opportunities
Expansion of IoT and AI in Healthcare Offers Growth Opportunity
The integration of Internet of Things (IoT) and Artificial Intelligence (AI) in healthcare presents significant growth opportunities for smart medical devices. IoT-enabled devices can collect and transmit real-time patient data, enhancing continuous monitoring and immediate responses. AI algorithms analyze this data, offering personalized healthcare insights and decision support.
For instance, wearable ECG monitors like the Withings Move ECG use IoT and AI to detect atrial fibrillation, allowing for early detection and timely intervention. According to a report, the global Generative AI in healthcare market is expected to be worth around USD 17.2 Bn by 2032 from USD 0.8 Bn in 2022, growing at a CAGR of 37.0% during the forecast period from 2023 to 2032. This integration of IoT and AI is set to revolutionize patient care, improving outcomes and creating a substantial market for advanced smart medical devices.
Telehealth and Remote Patient Monitoring Offers Growth Opportunity
The rise of telehealth services and remote patient monitoring creates numerous opportunities for smart medical devices. These technologies facilitate continuous health monitoring outside traditional healthcare settings, allowing early detection of health issues and reducing hospital burdens.
TytoCare's telehealth solution, which includes a handheld device for remote physical exams and consultations, exemplifies this trend. This shift towards remote healthcare increases the demand for smart medical devices, enhancing access to healthcare in remote and underserved areas, thereby driving market growth.
Trending Factors
Wearable Health Technology Are Trending Factors
The trend towards wearable health technology significantly boosts the growth of smart medical devices. Wearable devices like smartwatches and fitness trackers are increasingly incorporating health monitoring features such as heart rate monitoring, sleep tracking, and activity analysis.
This trend is driven by consumer demand for devices that provide actionable health insights and promote proactive health management. Fitbit's Sense smartwatch, for example, includes ECG monitoring, stress management tools, and temperature tracking, catering to the growing interest in comprehensive health monitoring. The global wearable medical device market is expected to grow at a CAGR of 13.6% from 2023 to 2032, reflecting the increasing consumer interest in health and fitness tracking.
Home Healthcare and Aging Population Are Trending Factors
The shift towards home healthcare solutions, coupled with the aging population, drives the adoption of smart medical devices that support independent living and remote monitoring. These devices enable seniors to manage chronic conditions and age-related health issues from the comfort of their homes, reducing hospital visits and improving quality of life.
Philips' CareSage predictive analytics platform is an example of a smart medical device that uses AI to predict health deterioration in elderly patients, allowing for timely interventions and proactive care. The global home healthcare market is projected to reach USD 515.6 billion by 2027, growing at a CAGR of 7.9%. This trend underscores the increasing demand for smart medical devices in home care settings, facilitating better health management for the aging population.
Regional Analysis
North America Dominates with 43.87% Market Share
North America's dominance in the smart medical devices market, with a 43.87% share, is driven by several key factors. The region's advanced healthcare infrastructure, high adoption rate of technology, and significant investment in healthcare research and development contribute to this leadership. The presence of major industry players, such as Abbott Laboratories and Medtronic, further strengthens North America's market position.
North America's high market share is attributed to its well-established healthcare system and high healthcare expenditure. The region leads in technological innovation and rapid adoption of advanced medical technologies. Strong support from government initiatives and favorable reimbursement policies enhance market growth. Additionally, the rising prevalence of chronic diseases, such as diabetes and cardiovascular conditions, boosts the demand for smart medical devices.
Other Regions
Europe: Europe holds a significant share of the market, with a projected growth rate of 8.5% CAGR. The region's strong healthcare system, regulatory support, and high awareness of health technologies contribute to its market share. Countries like Germany, the UK, and France are leading contributors.
Asia Pacific: Asia Pacific is the fastest-growing region, with a market share of 29.4%. The region's growth is driven by increasing healthcare expenditure, a large patient population, and rapid technological advancements. China, Japan, and India are key markets within this region, showing substantial growth potential.
Middle East & Africa: The Middle East & Africa region holds a smaller market share, around 6.3%, but is experiencing steady growth. Improved healthcare infrastructure, increasing adoption of smart medical devices, and rising awareness about chronic diseases contribute to market expansion.
Latin America: Latin America has a market share of approximately 5.3%. The region's growth is supported by improving healthcare facilities and growing investments in healthcare technology. Brazil and Mexico are the major contributors to the market in this region, showing promising growth trends.
Key Regions and Countries
- North America
- The US
- Canada
- Mexico
- Western Europe
- Germany
- France
- The UK
- Spain
- Italy
- Portugal
- Ireland
- Austria
- Switzerland
- Benelux
- Nordic
- Rest of Western Europe
- Eastern Europe
- Russia
- Poland
- The Czech Republic
- Greece
- Rest of Eastern Europe
- APAC
- China
- Japan
- South Korea
- India
- Australia & New Zealand
- Indonesia
- Malaysia
- Philippines
- Singapore
- Thailand
- Vietnam
- Rest of APAC
- Latin America
- Brazil
- Colombia
- Chile
- Argentina
- Costa Rica
- Rest of Latin America
- Middle East & Africa
- Algeria
- Egypt
- Israel
- Kuwait
- Nigeria
- Saudi Arabia
- South Africa
- Turkey
- United Arab Emirates
- Rest of MEA
Key Players Analysis
The smart medical devices market is highly competitive, with several key players driving innovation and market growth. Abbott Laboratories is a major player known for its continuous glucose monitoring systems, which have revolutionized diabetes management. Apple, Inc. has significantly impacted the market with its Apple Watch series, incorporating advanced health monitoring features like ECG and blood oxygen levels.
Dexcom, Inc. is another leader in glucose monitoring technology, offering continuous glucose monitoring devices that enhance diabetes care. Fitbit, Inc., now part of Google, has integrated health tracking features into its wearables, promoting proactive health management. F. Hoffmann-La Roche Ltd. excels in diagnostics, providing advanced monitoring devices that improve patient outcomes.
Johnson & Johnson and Medtronic plc are dominant in the therapeutic devices segment, offering a range of products for chronic disease management. NeuroMetrix, Inc. focuses on neurostimulation devices, addressing chronic pain and neurological disorders. Samsung Electronics Co., Ltd. leverages its technological expertise to offer innovative health monitoring solutions through its wearable devices. Sonova is a key player in the hearing aids market, enhancing auditory health with advanced hearing solutions.
These companies strategically position themselves through continuous innovation, strategic partnerships, and extensive R&D investments. Their market influence is evident in their robust product portfolios and widespread adoption of their devices, driving the growth and evolution of the smart medical devices market.
Market Key Players
- Abbott Laboratories
- Apple, Inc.
- Dexcom, Inc.
- Fitbit, Inc.
- F. Hoffmann-La Roche Ltd.
- Johnson & Johnson
- Medtronic plc
- NeuroMetrix, Inc.
- Samsung Electronics Co., Ltd.
- Sonova
- F. Hoffmann-La Roche Ltd
Recent Developments
- On April 24, 2024, the article "The Next Gen of Smart Pills Will Transform Personalized Care" discusses the advancements in smart pills, highlighting the potential impact on personalized care. It mentions the importance of clinical validation, accessibility, and insurance coverage in shaping the role of these smart pills.
- On April 3, 2024, researchers introduced a novel blockchain system called HNMBlock to enhance medical device monitoring and cybersecurity in healthcare. This system integrates blockchain technology with medical devices to ensure secure data storage and retrieval, aiming to revolutionize the medical industry by improving security and patient privacy.
- On April 30, 2024, Samsung announced the upcoming launch of a smart health device called Galaxy Ring. This ring-shaped health device aims to complement the existing Galaxy Watch by providing continuous health monitoring and analysis, offering a different form factor for users who prefer not to wear a watch all the time.
Report Scope
Report Features Description Market Value (2023) USD 37.3 Billion Forecast Revenue (2033) USD 75.5 Billion CAGR (2024-2033) 7.5% Base Year for Estimation 2023 Historic Period 2018-2023 Forecast Period 2024-2033 Report Coverage Revenue Forecast, Market Dynamics, Competitive Landscape, Recent Developments Segments Covered By Product Type (Diagnostic and Monitoring Devices, Modality - Wearable, Non-Wearable, Therapeutic Devices, Injury Prevention and Rehabilitation Devices), By Application (Blood glucose & pressure monitoring, Cardiovascular monitoring, Fetal Monitors, Pulse Oximeters, Breathe Analyzers, Body Motion, Insulin Monitoring, Hearing aids, Others), By End-user (Hospitals, Clinics, Home Care Settings, Others), Distribution Channel (Pharmacies, Online channel, Others - hypermarkets) Regional Analysis North America - The US, Canada, & Mexico; Western Europe - Germany, France, The UK, Spain, Italy, Portugal, Ireland, Austria, Switzerland, Benelux, Nordic, & Rest of Western Europe; Eastern Europe - Russia, Poland, The Czech Republic, Greece, & Rest of Eastern Europe; APAC - China, Japan, South Korea, India, Australia & New Zealand, Indonesia, Malaysia, Philippines, Singapore, Thailand, Vietnam, & Rest of APAC; Latin America - Brazil, Colombia, Chile, Argentina, Costa Rica, & Rest of Latin America; Middle East & Africa - Algeria, Egypt, Israel, Kuwait, Nigeria, Saudi Arabia, South Africa, Turkey, United Arab Emirates, & Rest of MEA Competitive Landscape Abbott Laboratories, Apple, Inc., Dexcom, Inc., Fitbit, Inc., F. Hoffmann-La Roche Ltd., Johnson & Johnson, Medtronic plc, NeuroMetrix, Inc., Samsung Electronics Co., Ltd, Sonova, F. Hoffmann-La Roche Ltd Customization Scope Customization for segments, region/country-level will be provided. Moreover, additional customization can be done based on the requirements. Purchase Options We have three licenses to opt for: Single User License, Multi-User License (Up to 5 Users), Corporate Use License (Unlimited User and Printable PDF) -
-
- Abbott Laboratories
- Apple, Inc.
- Dexcom, Inc.
- Fitbit, Inc.
- F. Hoffmann-La Roche Ltd.
- Johnson & Johnson
- Medtronic plc
- NeuroMetrix, Inc.
- Samsung Electronics Co., Ltd.
- Sonova
- F. Hoffmann-La Roche Ltd